EGIS-11150

N/A

Report date: 2022/02/21 13:52:42
NME

Base Information

Drug NameEGIS-11150
Drug Alias NameEGIS-11150S-36549E-11150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 7 (5-HT7) receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonistsAdrenergic receptors antagonists +[4] 
TargetsSerotonin 7 (5-HT7) receptorSerotonin 2a (5-HT2a) receptorAdrenergic receptors +[4] 
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEgis PharmaceuticalsLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis PharmaceuticalsLes Laboratoires Servier
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A